Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Taxes (2016 - 2025)

Bio-Techne has reported Change in Taxes over the past 17 years, most recently at $4.6 million for Q4 2025.

  • Quarterly results put Change in Taxes at $4.6 million for Q4 2025, up 213.33% from a year ago — trailing twelve months through Dec 2025 was -$4.1 million (up 62.11% YoY), and the annual figure for FY2025 was $8.5 million, up 179.9%.
  • Change in Taxes for Q4 2025 was $4.6 million at Bio-Techne, up from -$27.4 million in the prior quarter.
  • Over the last five years, Change in Taxes for TECH hit a ceiling of $16.4 million in Q2 2025 and a floor of -$27.4 million in Q3 2025.
  • Median Change in Taxes over the past 5 years was $925500.0 (2021), compared with a mean of -$766950.0.
  • Biggest five-year swings in Change in Taxes: crashed 1332.97% in 2021 and later skyrocketed 254.55% in 2025.
  • Bio-Techne's Change in Taxes stood at $13.7 million in 2021, then decreased by 23.49% to $10.5 million in 2022, then grew by 24.34% to $13.1 million in 2023, then crashed by 130.93% to -$4.0 million in 2024, then soared by 213.33% to $4.6 million in 2025.
  • The last three reported values for Change in Taxes were $4.6 million (Q4 2025), -$27.4 million (Q3 2025), and $16.4 million (Q2 2025) per Business Quant data.